VI
ADMA icon

Vestcor Inc’s ADMA Biologics ADMA Stock Holding History

Vestcor Inc’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$192K Hold
21,326
– – 0.01% 1037
2025
Q4 		$389K Sell
21,326
-26,796
-56% -$452K 0.01% 787
2025
Q3 		$705K Buy
48,122
+19,593
+69% +$336K 0.02% 605
2025
Q2 		$520K Buy
+28,529
New +$582K 0.02% 681

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Vestcor Inc's ADMA Position: Q1 2026 in Review

Vestcor Inc held its ADMA Biologics (ADMA) position steady in Q1 2026 at 21,326 shares worth $192K. The position accounts for 0.01% of the portfolio, ranked #1037.

Vestcor Inc first reported a position in ADMA in Q2 2025 and has held it in 4 quarters since. The position peaked at $705K in Q3 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Vestcor Inc held 21,326 shares of ADMA Biologics worth $192K as of Q1 2026.
  • Vestcor Inc left its ADMA Biologics share count unchanged in Q1 2026.
  • ADMA Biologics made up 0.01% of Vestcor Inc's portfolio in Q1 2026, its #1037 holding.
  • Vestcor Inc first reported a position in ADMA Biologics in Q2 2025 and has held it in 4 quarters since.
  • Vestcor Inc's ADMA Biologics position peaked at $705K in Q3 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.